Hereditary Neuropathy
Gene: PMP22
Addition of studies to support GREEN AR GDA with PMP22. The reported affected individuals present with infantile/early-onset CMT/ Dejerine‑Sottas disease (which is now known as CMT type 3).
AD GDA (GREEN)
Classified as Definitive ClinGen CMT GCEP in association with Charcot-Marie-Tooth disease type 1A - https://search.clinicalgenome.org/CCID:005837
Classified as Definitive by ClinGen CMT GCEp in association with hereditary neuropathy with liability to pressure palsies - https://search.clinicalgenome.org/CCID:008314Created: 25 Feb 2026, 8:35 p.m. | Last Modified: 25 Feb 2026, 8:35 p.m.
Panel Version: 1.179
Well established gene-disease association. Note mechanism is often CNV.Created: 31 Jul 2020, 9:47 a.m. | Last Modified: 31 Jul 2020, 9:47 a.m.
Panel Version: 0.3608
Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Phenotypes
Charcot-Marie-Tooth disease, type 1A, MIM# 118220; Charcot-Marie-Tooth disease, type 1E, MIM# 118300; Dejerine-Sottas disease, MIM# 145900; Neuropathy, recurrent, with pressure palsies 162500; Roussy-Levy syndrome 180800
Publications
PMID: 32356557 - Pantera et al 2020 - investigate the effect of a distal super-enhancer domain on the expression of PMP22. Loss of the super-enhancer in mice reduces Pmp22 expression throughout development and into adulthood. The mice display tomacula formed by excessive myelin folding, which is a pathological hallmark of HNPP (hereditary neuropathy with liability to pressure palsies). The findings demonstrate a mechanism by which smaller copy number variations, not including the Pmp22 gene, are sufficient to reduce gene expression and phenocopy a peripheral neuropathy caused by the HNPP-associated deletion encompassing PMP22.Created: 31 Jul 2020, 12:17 a.m. | Last Modified: 31 Jul 2020, 12:17 a.m.
Panel Version: 0.3590
Publications
Comment on list classification: Both SNVs and CNVs cause diseaseCreated: 16 Jun 2020, 2:57 p.m. | Last Modified: 16 Jun 2020, 2:57 p.m.
Panel Version: 0.46
Gene: pmp22 has been classified as Green List (High Evidence).
Phenotypes for gene: PMP22 were changed from Charcot Marie Tooth disease, type 1A, 118220; Roussy Levy syndrome, 180800; Neuropathy, inflammatory demyelinating, 139393; Neuropathy, recurrent, with pressure palsies, 162500; Charcot Marie Tooth disease, type 1E, 118300; Dejerine Sottas disease, 145900; HMSN to Charcot-Marie-Tooth disease, type 1A, MIM# 118220; Charcot-Marie-Tooth disease, type 1E, MIM# 118300; Dejerine-Sottas disease, MIM# 145900; Neuropathy, recurrent, with pressure palsies 162500; Roussy-Levy syndrome 180800
Publications for gene: PMP22 were set to
Mode of inheritance for gene: PMP22 was changed from MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal
gene: PMP22 was added gene: PMP22 was added to Hereditary Neuropathy. Sources: Expert Review Green,Expert Review Green,Royal Melbourne Hospital,Victorian Clinical Genetics Services SV/CNV tags were added to gene: PMP22. Mode of inheritance for gene: PMP22 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Phenotypes for gene: PMP22 were set to Charcot Marie Tooth disease, type 1A, 118220; Roussy Levy syndrome, 180800; Neuropathy, inflammatory demyelinating, 139393; Neuropathy, recurrent, with pressure palsies, 162500; Charcot Marie Tooth disease, type 1E, 118300; Dejerine Sottas disease, 145900; HMSN